Scolaris Content Display Scolaris Content Display

Cochrane Database of Systematic Reviews

Factor estimulante de colonias de granulocitos (G‐CSF) como adyuvante de los antibióticos en el tratamiento de la neumonía en adultos

Información

DOI:
https://doi.org/10.1002/14651858.CD004400.pub3Copiar DOI
Base de datos:
  1. Cochrane Database of Systematic Reviews
Versión publicada:
  1. 18 abril 2007see what's new
Tipo:
  1. Intervention
Etapa:
  1. Review
Grupo Editorial Cochrane:

  1. Grupo Cochrane de Infecciones respiratorias agudas

Copyright:
  1. Copyright © 2010 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Cifras del artículo

Altmetric:

Citado por:

Citado 0 veces por enlace Crossref Cited-by

Contraer

Autores

  • Allen C Cheng

    Correspondencia a: Department of Epidemiology and Preventive Medicine, Monash University, 2nd Floor, Burnet Centre, Alfred Hospital, Melbourne, Australia

    [email protected]

  • Dianne P Stephens

    Intensive Care Unit, Royal Darwin Hospital, Darwin, Australia

  • Bart J Currie

    Northern Territory Clinical School, Menzies School of Health Research, Charles Darwin University and Northern Territory Clinical School, Casuarina, Australia

Contributions of authors

AC and BC conceived the idea, AC and DS reviewed the papers and AC drafted the protocol and review. All authors contributed to data analysis and revisions to the draft.

Sources of support

Internal sources

  • No sources of support supplied

External sources

  • National Health and Medical Research Council, Australia.

Declarations of interest

We conducted a randomized controlled trial of the use of G‐CSF in septic shock included in this review (Cheng 2006) and received a donation of product from Merck, formerly the Australian distributor of lenograstim. We have no other conflict of interest; in particular, we have not received financial support from pharmaceutical companies for this proposed study.

Acknowledgements

The authors wish to acknowledge the support and advice of Dr Peter Morris. We thank Dr Mary Ann Foote at Amgen and A/Prof John Wilson at the Alfred Hospital, Melbourne for supplying unpublished data from the Amgen‐sponsored trials and Dr Thilo Kober and Prof Andreas Engert for unpublished details of the German trial. We also wish to thank the following people for commenting on this update: Frauke Naumann, PHD and Olaf Weingart, MD from the Editorial Base of the Cochrane Haematological Malignancies Group (CHMG) at University Hospital Cologne, which was funded by the German Federal Ministry of Education and Research (BMBF) FKZ: 01GH5021, Nicky Coote, Rebecca Coghlan, Mark Jones and George Swingler.

Version history

Published

Title

Stage

Authors

Version

2007 Apr 18

Granulocyte‐Colony Stimulating Factor (G‐CSF) as an adjunct to antibiotics in the treatment of pneumonia in adults

Review

Allen C Cheng, Dianne P Stephens, Bart J Currie

https://doi.org/10.1002/14651858.CD004400.pub3

2004 Jul 19

Granulocyte‐Colony Stimulating Factor (G‐CSF) as an adjunct to antibiotics in the treatment of pneumonia in adults

Review

Allen C Cheng, Dianne P Stephens, Bart J Currie

https://doi.org/10.1002/14651858.CD004400.pub2

2003 Oct 20

Granulocyte‐Colony Stimulating Factor (G‐CSF) as an adjunct to antibiotics in the treatment of pneumonia in adults

Review

Allen C Cheng, Dianne P Stephens, Bart J Currie

https://doi.org/10.1002/14651858.CD004400

PICO

Population
Intervention
Comparison
Outcome

El uso y la enseñanza del modelo PICO están muy extendidos en el ámbito de la atención sanitaria basada en la evidencia para formular preguntas y estrategias de búsqueda y para caracterizar estudios o metanálisis clínicos. PICO son las siglas en inglés de cuatro posibles componentes de una pregunta de investigación: paciente, población o problema; intervención; comparación; desenlace (outcome).

Para saber más sobre el uso del modelo PICO, puede consultar el Manual Cochrane.